Canopy Growth Corporation (CGC) vs Alpha Teknova, Inc. (TKNO)

Canopy Growth Corporation and Alpha Teknova, Inc. are both Drug Manufacturers Specialty & Generic companies. Alpha Teknova, Inc. is the larger, with a market value of $486.2M against $283.5M — 1.7× the size. Alpha Teknova, Inc. grew revenue faster over the last twelve months: 15.5% against 7.80%. Alpha Teknova, Inc. has the higher net margin (−34.8% vs −80.4%) and the higher return on invested capital (−16.6% vs −17.2%). Across the 18 metrics below, Alpha Teknova, Inc. leads on 14 and Canopy Growth Corporation on 4.

Valuation

Metric CGC TKNO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 1.35 9.15 2.08
P/B 0.58 7.03 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 1.01 9.17 2.87
Earnings yield (65.34%) (3.70%) (15.94%)
Free cash flow yield (21.13%) (1.52%) 0.00%

Profitability

Metric CGC TKNO Drug Manufacturers Specialty & Generic median
Gross margin 25.16% 36.43% 53.51%
Operating margin (54.89%) (32.65%) 0.00%
Net margin (80.39%) (34.76%) (2.45%)
Free cash flow margin (28.34%) (13.89%) 0.00%
Return on equity (40.14%) (24.12%) (0.80%)
Return on assets (23.54%) (15.79%) (1.67%)
Return on invested capital (17.19%) (16.60%) 0.00%

Growth

Metric CGC TKNO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 7.80% 15.45% 5.22%
EPS growth (last fiscal year) 84.00% 43.86% 42.91%
Revenue growth, 5-year CAGR (13.04%) 5.30% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CGC TKNO Drug Manufacturers Specialty & Generic median
Debt to equity 0.35 0.22 0.04
Current ratio 3.04 3.56 2.41
Net debt to EBITDA 1.09 0.75 1.01

Dividend

Metric CGC TKNO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric CGC TKNO Drug Manufacturers Specialty & Generic median
Market cap 283.50m 486.22m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack